SARS-CoV-2 Vaccination Efficacy & Safety in Lung Transplantation Recipients: A Single Centre Study

PURPOSE: Solid Organ Transplant recipients (SOT) are at higher risk of SARS-CoV-2 infection. Mortality rates reported between 13 to over 30% in SOT recipients. SARS‐CoV‐2 vaccination may help reduce the morbidity and mortality of COVID‐19 among SOT. There is paucity of literature of SARS-CoV-2 vacci...

Descripción completa

Detalles Bibliográficos
Autores principales: Shah, U., Rahulan, V., Ravipati, S., Kumar, S., Kamath, A., Kori, S., Panda, S., Kumar, P., John, P., BN, M., Dutta, P., Attawar, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Inc. 2022
Materias:
(1313)
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988626/
http://dx.doi.org/10.1016/j.healun.2022.01.1334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8988626/
http://dx.doi.org/10.1016/j.healun.2022.01.1334

Ejemplares similares